XML 32 R23.htm IDEA: XBRL DOCUMENT v3.25.2
Segments
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Segments

15. Segments

We operate as a single operating segment focused on developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on our T-win® platform. As the chief operating decision maker (“CODM”), our Chief Executive Officer manages our company, reviews operating results, assesses performance and allocates resources on an aggregate basis using consolidated net income or loss as the key measure of segment profit or loss. As such, results of our operations are reported on a consolidated basis for purposes of management and segment reporting. Please refer to the consolidated financial statements for further information related to these measures of segment performance.

In addition, research and development and general and administrative expenses are significant segment expenses regularly provided to the CEO with the following categories (in thousands):

Research and Development

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

(in thousands)

 

 

(in thousands)

 

Clinical trial-related activities

 

$

6,390

 

 

$

6,637

 

 

$

14,081

 

 

$

13,785

 

Personnel

 

 

6,531

 

 

 

5,123

 

 

 

12,714

 

 

 

9,917

 

Chemistry, manufacturing and control

 

 

2,484

 

 

 

2,994

 

 

 

4,776

 

 

 

5,161

 

Preclinical studies and activities

 

 

616

 

 

 

295

 

 

 

1,028

 

 

 

632

 

Other costs

 

 

631

 

 

 

799

 

 

 

428

 

 

 

664

 

Total research and development expenses

 

$

16,652

 

 

$

15,848

 

 

$

33,027

 

 

$

30,159

 

General and Administrative

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

(in thousands)

 

 

(in thousands)

 

Personnel

 

$

2,840

 

 

$

2,899

 

 

$

5,852

 

 

$

5,693

 

Professional services

 

 

1,743

 

 

 

975

 

 

 

3,124

 

 

 

2,048

 

Other costs

 

 

1,935

 

 

 

1,811

 

 

 

3,751

 

 

 

3,830

 

Total general and administrative expenses

 

$

6,518

 

 

$

5,685

 

 

$

12,727

 

 

$

11,571